Literature DB >> 25738115

Association of micro albuminuria with diastolic function in obese normotensive no diabetic individuals.

Farzanehsadat Minoo1, Mitra Mahdavi Mazdeh2, Mohamad Reza Abasi1.   

Abstract

BACKGROUND: Recently, an association between impaired diastolic function and increased urinary albumin excretion has been hypothesized.
OBJECTIVES: We tried to assess the association between diastolic function and micro albuminuria in normotensive no diabetic obese individuals. PATIENTS AND METHODS: This cross-sectional study was conducted on 186 consecutive obese normotensive no diabetic individuals who were older than 18 years and attended the outpatient health clinic at the Tehran Municipality in 2011. Systolic and diastolic blood pressures were measured using a standard mercury sphygmomanometer. Micro albuminuria was defined as abnormal urinary albumin to creatinine ratio (UACR) between 30 and 300 mg/g/d.
RESULTS: An adverse significant linear correlations was found between the UACR measurement and diastolic function (r = -0.184 and P = 0.012); however, this correlation was insignificant for systolic function (r = 0.007 and P = 0.926). Multivariable linear regression analysis showed that UACR index had a significant reverse correlation with diastolic function (Standardized Beta = -0.218 and P = 0.006).
CONCLUSIONS: Our study obtained some evidences on the association of micro albuminuria with diastolic dysfunction in obese normotensive no diabetic individuals. Nonetheless, more assessment is necessary for obtaining a causal relationship between micro albuminuria and diastolic dysfunction.

Entities:  

Keywords:  Blood Pressure; Body Mass Index; Micro Albuminuria; Obesity

Year:  2014        PMID: 25738115      PMCID: PMC4330686          DOI: 10.5812/numonthly.22386

Source DB:  PubMed          Journal:  Nephrourol Mon        ISSN: 2251-7006


1. Background

Some clinical studies have identified an alteration of cardiac diastolic function in healthy obese patients. It has been demonstrated that obesity could be associated with increased left ventricular (LV) end-diastolic pressure, which suggests an association between obesity and diastolic dysfunction. Albuminuria is a morbidity of obesity. These two abnormalities can be observe in obesity and can contribute to the prevalence of heart failure and chronic kidney disease in obese patients (1). Nevertheless, we do not know whether these two factors are definitely correlated. If there is any correlation between two factors, physicians should assess second factor when they found first. Micro albuminuria and impaired diastolic function in addition to ventricular remodeling and elevated filling pressures can contribute to the prevalence of heart failure in obese patients (1). These early subclinical abnormalities in LV structure and function might have important implications for explaining the diastolic myocardial dysfunction in obese individuals (2, 3). Thus, weight control might reduce these adverse abnormalities such as LV remodeling and preserve LV function (4). Hypertension (HTN) and diabetes are independently associated with impaired LV diastolic function (5). Several reports have shown that LV diastolic dysfunction is present in patients with diabetes or HTN, even in the absence of the alterations of ventricular systolic function (6-9). However, some evidences indicated diastolic dysfunction with unknown processes in normotensive or non-diabetic subjects (10, 11). Micro proteinuria is a powerful and independent risk factor for cardiovascular morbidity and mortality in diabetic and no diabetic individuals. Body mass index (BMI) has been shown to be significantly correlated with albumin excretion rate and kidney volume and therefore, severe obesity is associated with increased renal plasma flow and glomerular filtration rate (12). In addition, obesity-related glomerular hyper filtration ameliorates after weight loss and the improvement in hyper filtration can prevent the development of overt obesity-related glomerulopathy (13). Some investigators revealed that an elevated albumin excretion rate was associated with an increased diastolic dysfunction (14-16).

2. Objectives

We aimed to assess the association between diastolic function and appearance of micro albuminuria in normotensive no diabetic obese individuals.

3. Patients and Methods

The current cross-sectional study was conducted on consecutive obese individuals (BMI ≥ 30 kg/m2) who were older than 18 years and attended the outpatient health clinic at the Tehran Municipality in 2011. Exclusion criteria were history of diabetes mellitus, HTN, hyperlipidemia, cigarette smoking, any renal or liver disorders, urinary tract infections, or menstruation phase of the menstrual cycle. The study was conducted after taking the required ethical clearance from the Ethic Review Board and all patients signed an informed consent. Baseline data were collected through face-to-face interview and included demographic characteristics and educational level. Weight was measured using a balance standard scale and standing height was measured using a single tape measure. Blood pressure was measured using a standard mercury sphygmomanometer. Diastolic and systolic functions were assessed by a cardiologist through echocardiography. All of the obese patients were referred to one cardiologist and one device was used for echocardiography. Hence, interpersonal and inter-device variability were omitted. Around 5 mL of spot urine sample in a sterile container was collected for determination of spot urinary albumin excretion and urinary creatinine. The urinary albumin was measured by immunonephelometric assay, and urinary creatinine was calculated by automated enzymatic assay. Urinary albumin excretion was calculated as urinary albumin to creatinine ratio (UACR). UACR was calculated as milligram of albumin per gram of creatinine. Micro albuminuria was defined as abnormal values of UACR (≥ 30 mg/g). After ten to 12 hours of overnight fasting, blood samples were collected for estimation of fasting blood sugar (FBS) and serum creatinine. FBS was assayed by glucose oxidase assay kit (Pars Azmoon Ltd. Iran) and serum creatinine was measured by automated enzymatic assay. Results were reported as mean ± standard deviation (SD) for the quantitative variables and percentages for the categorical variables. The groups were compared using the Student's t test and the Chi square test (or Fisher's exact test if required) for the continuous and categorical variables, respectively. Correlations between the quantitative variables were examined by the Pearson’s correlation test. Predictors that exhibited a statistically significant association with micro albuminuria were taken for multivariate logistic regression analysis to investigate their independence as predictors. Odds ratio (OR) and 95% confidence intervals (95% CI) were calculated. This study was done with the power of 80%. P values < 0.05 were considered statistically significant. All the statistical analyses were performed using SPSS 13.0 (SPSS Inc., Chicago, IL, USA) and SAS 9.1 for Windows (SAS Institute Inc., Cary, NC, USA).

4. Results

The baseline data of the patients are summarized in Table 1. A total of 186 normotensive no diabetic obese individuals were enrolled. The mean age of the subjects was 39.4 years (range, 19-66) with the majority of them being female. The mean BMI was 32.8 kg/m2 and among them, 17.7% had severe obesity (BMI ≥ 35 kg/m2). On the first admission day, systolic and diastolic blood pressures were controlled in the normal ranges in all study population. No significant difference in demographic characteristics was found between those with or without micro albuminuria. There were also no significant differences in the baseline laboratory indices including FBS as well as serum creatinine level between two groups.
Table 1.

Baseline Characteristics of the Study Groups [a,b]

Characteristics Total (n = 186)UACR (+) (n = 22)UACR (-) (n = 164)P value
Gender, Male 11 (5.9)11 (6.8)0 (0.0)0.367
Age, y 39.4/10.739.2/9.239.4/10.90.921
Weight, kg 86.5/8.287.9/8.686.3/8.10.426
Body mass index, kg/m 2 32.8/2.633.8/3.332.7/2.50.075
Education level 0.654
Primary80 (43.7)8 (36.4)72 (44.7)
Secondary 75 (41.0)11 (50.0)64 (39.8)
College degree28 (15.3)3 (13.6)25 (15.5)
Fasting blood sugar, g/dL 96.0/23.9100.2/23.795.4/24.00.385
Serum creatinine, mg/dL 0.83/0.110.82/0.110.83/0.110.565

a Abbreviations: UACR, urinary albumin to creatinine ratio; BMI, body mass index; and FBS, fasting blood sugar.

b Data are presented as No. (%) or ratio.

In univariate regression analysis, a significant correlation between UACR and diastolic function, male sex, age, BMI, serum creatinine, and FBS (P < 0.05) was found. However, the correlation between UACR and weight or educational level was insignificant (P > 0.05). Therefore, we used multivariate regression analysis for UACR and diastolic function, male sex, age, BMI, creatinine, and FBS to investigate their independence as predictor (Table 2) and only a significant correlation between UACR and diastolic function was found; hence, so diastolic function was independent factor.
Table 2.

Association Between Microalbuminuria and Diastolic Function in the Presence of Other Variables as Probable Cofounders

Variable Standardized BetaT ScoreP value
Diastolic Function -0.218-2.7770.006
Male, Gender 0.0240.3110.756
Age 0.090.1280.898
Body Mass Index -0.004-0.0540.957
Serum Creatinine -0.030-0.3880.699
Fasting Blood Sugar 0.0861.1050.271
A reverse significant linear correlations was found between the UACR and diastolic function (r = -0.184 and P = 0.012), while the correlation between UACR and systolic function was insignificant (r = 0.007 and P = 0.926). Multivariable linear regression analysis (Table 2) showed that the UACR had a significant reverse correlation with diastolic function (Standardized Beta = -0.218 and P = 0.006). a Abbreviations: UACR, urinary albumin to creatinine ratio; BMI, body mass index; and FBS, fasting blood sugar. b Data are presented as No. (%) or ratio.

5. Discussion

We observed a reverse association between diastolic dysfunction and UACR, which indicated a negative association between micro albuminuria and diastolic function. Some observations have shown that the more relevant impairment in diastolic function in patients with micro albuminuria could be related to the increased LV mass index with concentric remodeling (14). On the other hand, LV mass and LV wall thickness can be significantly increased and LV relaxation might be impaired in micro albuminuria (14). Picca et al. revealed that an elevated urinary albumin excretion rate was associated with an increased LV mass index, a higher prevalence of a concentric LV hypertrophy pattern, a depressed mid-wall systolic performance, and a markedly impaired diastolic function (15, 16). These evidences can confirm potential association between micro albuminuria and diastolic dysfunction. According to this fact that the diastolic function can be directly dependent to some pointed structural and functional indices, these cardiac indices should be assessed in those with the evidences of micro albuminuria, especially those who are suspected to have ventricular diastolic dysfunction. Our study focused on the presence of micro albuminuria in obese no diabetic normotensive patients; therefore, our finding was adjusted for other potential predisposing factors of micro albuminuria such as HTN and diabetes mellitus. In addition, the role of obesity in the development and progression of diastolic dysfunction has been more highlighted. Some studies revealed that obesity might be more important than micro albuminuria for the prediction and prevention of diastolic dysfunction in no diabetic patients (17). In this context, mediating role of inflammatory processes, particularly in normotensive no diabetic individuals, should not be ignored. It has been demonstrated that inflammatory fibrosis of the myocardium is a major cause of myocardial stiffening, which leads to dysfunction. The higher prevalence of proinflammatory conditions as well as higher levels of inflammatory markers can be often found in those with myocardial stiffening and diastolic dysfunction (18-22). Moreover, in acute inflammation, micro albuminuria might be a result of the endothelial glomerular leak in the kidneys, which is a manifestation of the systemic increases in capillary permeability due to an intense inflammatory onslaught on the endothelium (23, 24). Each acute inflammatory condition might lead to endothelial glomerular defects and finally result in micro albuminuria. Thus, the association between impaired diastolic function and micro albuminuria might be mediated by inflammatory processes. Therefore, those who are suspected of concurrent micro albuminuria and diastolic dysfunction, especially those with any evidence of heart failure, should be screened for acute or chronic inflammatory disorders. In summary, our results obtained some evidences regarding association between micro albuminuria and diastolic dysfunction in obese no diabetic normotensive individuals; however, more assessments are necessary for obtaining the casualty in this association.
  24 in total

Review 1.  Perspective on selected issues in cardiovascular disease research with a focus on black Americans.

Authors:  Michelle A Albert; Jose Torres; Robert J Glynn; Paul M Ridker
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

2.  Left ventricular diastolic function in normotensive type-2 diabetic subjects.

Authors:  Dike Ojji; Will Parsonage; Mark Dooris; Adewole Adebiyi; Oludolapo Oladapo; Jokotade Adeleye; Akinyemi Aje; Okechukwu Ogah; Adedeji Adebayo; Ayodele Falase; John Atherton
Journal:  J Natl Med Assoc       Date:  2008-09       Impact factor: 1.798

Review 3.  New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment.

Authors:  Michael R Zile; Dirk L Brutsaert
Journal:  Circulation       Date:  2002-03-26       Impact factor: 29.690

4.  Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease.

Authors:  Brian D Powell; Margaret M Redfield; Kevin A Bybee; William K Freeman; Charanjit S Rihal
Journal:  Am J Cardiol       Date:  2006-05-06       Impact factor: 2.778

5.  Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus.

Authors:  John K Boyer; Srihari Thanigaraj; Kenneth B Schechtman; Julio E Pérez
Journal:  Am J Cardiol       Date:  2004-04-01       Impact factor: 2.778

6.  Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging.

Authors:  Linda R Peterson; Alan D Waggoner; Kenneth B Schechtman; Timothy Meyer; Robert J Gropler; Benico Barzilai; Víctor G Dávila-Román
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

7.  The effects of weight loss on renal function in patients with severe obesity.

Authors:  Avry Chagnac; Tali Weinstein; Michal Herman; Judith Hirsh; Uzi Gafter; Yaacov Ori
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

8.  Association of albuminuria with impaired aortic elasticity and left ventricular diastolic dysfunction in type 2 diabetes.

Authors:  Dursun Duman; Refik Demirtunç; Bilgehan Karadağ; Meryem Karataş
Journal:  Anadolu Kardiyol Derg       Date:  2008-02

9.  Diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function.

Authors:  Virendra C Patil; Harsha V Patil; Kuldeep B Shah; Jay D Vasani; Pruthvi Shetty
Journal:  J Cardiovasc Dis Res       Date:  2011-10

10.  Body Mass Index or Microalbuminuria, Which One is More Important for the Prediction and Prevention of Diastolic Dysfunction in Non-diabetic Hypertensive Patients?

Authors:  Hasan Shemirani; Alireza Khosravi; Rohola Hemmati; Mojgan Gharipour
Journal:  Int J Prev Med       Date:  2012-03
View more
  1 in total

1.  Impact of the severity of obesity on microalbuminuria in obese normotensive nondiabetic individuals.

Authors:  Farzanehsadat Minoo; Mitra Mahdavi-Mazdeh; Mohamad-Reza Abbasi; Shahram Sohrabi
Journal:  J Renal Inj Prev       Date:  2015-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.